Coronavirus Diagnostics - Global Market Outlook (2018-2027)
According to Stratistics MRC, the Global Coronavirus Diagnostics Market is accounted for $4.64 billion in 2018 and is expected to reach $8.82 billion by 2027 growing at a CAGR of 7.4% during the forecast period. Exponential rise in cases of COVID-19 and growing healthcare spending and increasing need to protect the population from such outbreaks are the major factors propelling the market growth. However, factor such as lack of skilled nursing staff is hampering the market growth.
Coronavirus Diagnostics is a tremendously infectious disease caused by the Coronavirus. Symptoms and circumstances of the disease include mild to moderate respiratory discomfort. At the same time as most may get better without any need for special treatment, the virus can cause major issues or serious disease and even death in older individuals and persons with underlying medical problems such as diabetes, chronic respiratory diseases, and cancers.
Based on the type, the serology tests segment is going to have a lucrative growth during the forecast period due to these tests are done using blood samples. Further, these tests are helpful in determining patients with mild or no symptoms.
By geography, North America is likely to have a huge demand due to growing investments in R&D activities along with strong support from the governments in the regions are further expected to create huge market opportunities for diagnostic players over the next few years.
Some of the key players profiled in the Coronavirus Diagnostics Market include Abbott, Beckman Coulter, Becton,Dickinson and Company, bioMerieux, Bio-Rad Laboratories, GSK Biologicals, Hologic, Lonza, Ortho-Clinical Diagnostics, PerkinElmer, Qiagen and Roche Diagnostics.
• Molecular Tests (RT-PCR Tests)
• Serology Tests
• Diagnostic Kits
Time Durations Covered:
• 1 Hours to 12 Hours
• 13 Hours to 24 Hours
• 20-60 Minutes
• Less Than 20 Minutes
• More Than 24 Hours
Quantity of Users Covered:
• Physician Labs
• Private or Commercial Labs
• Public Health Labs
End Users Covered:
• Diagnostics Laboratories
• Research Institutes
• Health Centers & Clinics
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.